Qing Qin Selected Research

Qing Qin Research Topics

Disease

11	Neoplasms (Cancer) 12/2022 - 01/2013
5	Myocardial Infarction 01/2023 - 08/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2010
4	Inflammation (Inflammations) 01/2021 - 02/2013
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 09/2020 - 06/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 05/2015
2	Ischemia 01/2023 - 07/2020
2	Thrombosis (Thrombus) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 09/2021 - 03/2014
2	Fibrosis (Cirrhosis) 01/2021 - 11/2018
2	Pathologic Constriction (Stenosis) 08/2016 - 01/2013
2	Carcinogenesis 02/2016 - 06/2015
2	Lung Neoplasms (Lung Cancer) 03/2014 - 03/2014
2	Hypoxia (Hypoxemia) 10/2013 - 01/2013
2	Non-alcoholic Fatty Liver Disease 02/2013 - 01/2013
1	Atherosclerosis 01/2023
1	Neointima 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 12/2022
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Death (Near-Death Experience) 01/2021
1	Dyspnea (Shortness of Breath) 07/2020
1	Heart Failure 07/2020
1	Arteriosclerosis 01/2020
1	Lentivirus Infections 01/2020
1	Acute Coronary Syndrome 01/2020
1	Radiation Pneumonitis 01/2020
1	Glioma (Gliomas) 04/2019
1	Glioblastoma (Glioblastoma Multiforme) 04/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Disease Progression 01/2019
1	Diabetes Mellitus 09/2018
1	Infections 01/2018
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2016
1	Colonic Neoplasms (Colon Cancer) 02/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2015

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 01/2019 - 01/2013
3	omega-Chloroacetophenone (Mace)IBA 01/2023 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2015
2	MicroRNAs (MicroRNA)IBA 12/2022 - 04/2019
2	LigandsIBA 09/2021 - 01/2019
2	Eph Family Receptors (Eph Receptors)IBA 01/2021 - 01/2020
2	ProgranulinsIBA 01/2021 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2015
2	Peptides (Polypeptides)IBA 11/2018 - 03/2014
2	Insulin-Like Growth Factor I (IGF-1)IBA 09/2018 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 06/2016 - 05/2015
2	Therapeutic UsesIBA 03/2014 - 02/2013
2	Interleukin-18 (Interleukin 18)IBA 02/2013 - 01/2013
2	QuercetinIBA 02/2013 - 01/2013
2	CytokinesIBA 02/2013 - 01/2013
1	Messenger RNA (mRNA)IBA 12/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	CXC ChemokinesIBA 09/2021
1	Orphan Nuclear ReceptorsIBA 01/2021
1	EphA2 ReceptorIBA 01/2021
1	Gemcitabine FDA Link 09/2020
1	Capecitabine (Xeloda)FDA Link 09/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2020
1	InflammasomesIBA 01/2020
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	LuciferasesIBA 04/2019
1	Adenosine Triphosphate (ATP)IBA 04/2019
1	Glucose (Dextrose)FDA LinkGeneric 04/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	trametinibIBA 01/2019
1	dabrafenibIBA 01/2019
1	Glycogen Synthase KinasesIBA 11/2018
1	humaninIBA 11/2018
1	Insulin (Novolin)FDA Link 09/2018
1	Poly I-CIBA 01/2018
1	NucleotidesIBA 01/2018
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2018
1	Thrombospondin 1IBA 08/2016
1	Angiopoietin-2IBA 08/2016
1	EndostatinsIBA 08/2016
1	Gefitinib (Iressa)FDA Link 06/2016
1	Diphosphonates (Bisphosphonates)IBA 06/2016
1	Zoledronic Acid (Zometa)FDA Link 06/2016
1	Growth Factor ReceptorsIBA 06/2016
1	LipopolysaccharidesIBA 02/2016
1	Toll-Like Receptor 4IBA 02/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2016
1	CateninsIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	EnzymesIBA 06/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2015
1	Endothelin-1 (Endothelin 1)IBA 12/2014

Therapy/Procedure

3	Radiotherapy 12/2022 - 04/2019
3	Therapeutics 01/2022 - 12/2013
3	Percutaneous Coronary Intervention 01/2022 - 01/2013
3	Drug Therapy (Chemotherapy) 06/2015 - 12/2013
2	Ligation 01/2023 - 01/2021
2	Stents 01/2021 - 01/2021
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2020 - 01/2013
1	Length of Stay 01/2021
1	Adjuvant Chemoradiotherapy 09/2020